Stock BMY BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse
Other stock markets
 01:30:02 27/04/2024 am IST 		5-day change 1st Jan Change
44.85 USD +0.34% Intraday chart for Bristol-Myers Squibb Company -8.34% -12.59%
26/04 S&P 500 Q1 earnings estimated growth improves; stocks up for week RE
26/04 Leerink Partners Cuts Price Target on Bristol-Myers Squibb to $47 From $51 MT

Chart calendar Bristol-Myers Squibb Company

99e4241ea1a98df1a5be82905af87.fMnRdceB6MaNF7QfdmpWGzX7oJOYWURJtQHZsYXLuGc.Sv-yTPGyrY7JRdovGDw8cFmW2Mb6bicY9Em7ideEzAU_uaIR9eqGsOB57Q~10d35372b9424f1f5deb6c09db618c10

Upcoming events on Bristol-Myers Squibb Company

07/05/2024 07:30 pm Annual General Meeting
26/07/2024 04:29 pm Q2 2024 Earnings Release
26/07/2024 05:30 pm Q2 2024 Earnings Call
31/10/2024 04:29 pm Q3 2024 Earnings Release
31/10/2024 05:30 pm Q3 2024 Earnings Call
06/02/2025 05:29 pm Q4 2024 Earnings Release
06/02/2025 06:30 pm Q4 2024 Earnings Call
24/04/2025 04:29 pm Q1 2025 Earnings Release
24/04/2025 05:30 pm Q1 2025 Earnings Call
31/07/2025 04:29 pm Q2 2025 Earnings Release
31/07/2025 05:30 pm Q2 2025 Earnings Call
30/10/2025 04:29 pm Q3 2025 Earnings Release
30/10/2025 05:30 pm Q3 2025 Earnings Call
29/01/2026 Q4 2025 Earnings Release (Projected)
23/04/2026 Q1 2026 Earnings Release (Projected)

Past events on Bristol-Myers Squibb Company

25/04/2024 05:30 pm Q1 2024 Earnings Call
25/04/2024 04:29 pm Q1 2024 Earnings Release
07/04/2024 11:15 pm American College of Cardiology Scientific Meeting - Poster No 1075-09
07/04/2024 11:00 pm American College of Cardiology Scientific Meeting - Poster No: 1075-07
07/04/2024 10:45 pm American College of Cardiology Scientific Meeting - Abstract No: 1424-134
07/04/2024 09:30 pm American College of Cardiology Scientific Meeting - Poster No: 1065-11
07/04/2024 12:15 am American College of Cardiology Scientific Meeting - Poster No: 1306-157
06/04/2024 11:15 pm American College of Cardiology Scientific Meeting - Poster No: 1284-132
06/04/2024 09:15 pm American College of Cardiology Scientific Meeting - Poster No: 1244-128
04/04/2024 Ex-dividend day
03/04/2024 Schizophrenia International Research Society Congress
15/03/2024 Federal Register Oncologic Drugs Advisory Committee Meeting
14/03/2024 06:00 pm Barclays Global Healthcare Conference
13/03/2024 07:30 pm Leerink Partners Global Biopharma Conference
04/03/2024 08:20 pm TD Cowen Health Care Conference
29/02/2024 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P47
29/02/2024 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P47
29/02/2024 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P35
29/02/2024 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P09
29/02/2024 Americas Committee for Treatment And Research in Multiple Sclerosis Forum - Presentation Number: P09

Past dividends on Bristol-Myers Squibb Company

04/04/2024 Quarterly 0.6 USD
04/01/2024 Quarterly 0.6 USD
05/10/2023 Quarterly 0.57 USD
06/07/2023 Quarterly 0.57 USD
06/04/2023 Quarterly 0.57 USD
05/01/2023 Quarterly 0.57 USD
06/10/2022 Quarterly 0.54 USD
30/06/2022 Quarterly 0.54 USD
31/03/2022 Quarterly 0.54 USD
06/01/2022 Quarterly 0.54 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		26 145
26 418
-1.03%		42 518
42 189
0.78%		46 385
46 366
0.04%		46 159
45 911
0.54%		45 006
44 731
0.62%
45 964

EBITDA
Million USD		Released
Forecast
Spread 		9 945
9 754
1.96%		18 118
20 279
-10.65%		20 493
21 878
-6.33%		20 123
20 368
-1.2%		17 498
18 255
-4.15%
5 494

EBIT
Million USD		Released
Forecast
Spread 		8 199
8 540
-3.99%		17 426
17 664
-1.35%		19 830
19 963
-0.67%		19 442
18 924
2.73%		16 785
16 921
-0.8%
4 075

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		4 975
0,00
- 		-6 871
1 541
-545.88%		8 098
7 644
5.94%		7 713
7 912
-2.51%		8 440
8 846
-4.59%
-5 024

Net income
Million USD		Released
Forecast
Spread 		3 439
0,00
- 		-9 015
1 269
-810.58%		6 994
6 219
12.46%		6 327
6 617
-4.39%		8 025
7 823
2.58%
-4 811

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-3,99
0,53
-851.84%		3,12
2,78
12.07%		2,95
2,97
-0.55%		3,86
3,73
3.53%
-2,44

Announcement Date06/02/2004/02/2104/02/2202/02/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		11 648
11 343
2.69%		11 887
11 467
3.66%		11 218
11 180
0.34%		11 406
11 198
1.86%		11 337
11 498
-1.4%		11 226
11 811
-4.95%		10 966
10 959
0.06%		11 477
11 203
2.45%		11 865
11 451
3.62%
11 493


11 192


11 620


11 816


11 673

EBITDA
Million USD		Released
Forecast
Spread 		5 305
5 176
2.5%		7 812
5 060
54.38%		7 424
4 973
49.29%		4 288
4 594
-6.66%		5 030
4 732
6.3%		4 268
6 031
-29.24%		4 539
5 339
-14.98%		3 816
4 833
-21.04%		-8 984
-8 238
-9.05%
4 226


4 419


4 755







EBIT
Million USD		Released
Forecast
Spread 		5 267
4 848
8.63%		5 229
4 563
14.58%		4 836
4 622
4.62%		4 110
4 248
-3.26%		4 857
4 816
0.85%		4 251
4 785
-11.16%		4 360
4 206
3.66%		3 630
3 663
-0.91%		-8 329
-8 538
2.44%
4 186


4 053


4 224


4 906


4 630

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


1 958
2 118
-7.55%		2 209
2 139
3.27%		1 859
1 767
5.21%		2 770
2 808
-1.34%		1 859
2 836
-34.44%		2 137
2 216
-3.58%		1 674
2 000
-16.28%		-11 516



2 643


1 606


1 964







Net income
Million USD		Released
Forecast
Spread 		1 278


1 421
1 423
-0.11%		1 606
1 469
9.33%		2 022
1 444
40.03%		2 262
2 290
-1.24%		2 073
2 165
-4.23%		1 928
1 585
21.63%		1 762
1 479
19.13%		-11 911
-10 359
-14.98%
1 568


1 393


2 582







EPS
USD		Released
Forecast
Spread 		0,59
0,86
-31.4%		0,66
0,58
13.79%		0,75
0,71
5.63%		0,95
0,73
31.03%		1,07
1,19
-10.08%		0,99
1,16
-14.88%		0,93
0,89
4.03%		0,87
0,72
20.52%		-5,89
-4,84
-21.65%
0,87


0,80


1,26


1,82


1,70

Announcement Date29/04/2227/07/2225/10/2202/02/2327/04/2327/07/2326/10/2302/02/2425/04/24-----

Upcoming sector events for Bristol-Myers Squibb Company

29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
29/04/2024 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
29/04/2024 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
29/04/2024 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for Bristol-Myers Squibb Company

27/04/2024 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
27/04/2024 NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
27/04/2024 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
27/04/2024 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
27/04/2024 ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
27/04/2024 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
27/04/2024 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
27/04/2024 NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
27/04/2024 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
27/04/2024 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BMY Stock
  4. Calendar Bristol-Myers Squibb Company